BridgeBio Oncology Therap... (BBOT)
NASDAQ: BBOT
· Real-Time Price · USD
10.10
-1.98 (-16.39%)
At close: Aug 19, 2025, 3:59 PM
9.79
-3.07%
After-hours: Aug 19, 2025, 06:26 PM EDT
BridgeBio Oncology Therapeutics Stock Forecast
Stock Price Forecast
The 1 analysts with 12-month price forecasts for BBOT stock have an median target of 25, with a low estimate of 25 and a high estimate of 25. The median target predicts an increase of 147.52% from the current stock price of 10.10.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 25 | 25 | 25 | 25 |
| Change | 147.52% | 147.52% | 147.52% | 147.52% |
Latest Analyst Insight Report
According to 1 stock analyst, the rating for BridgeBio Oncology Therapeutics Inc. is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.
| Rating | Aug 25 |
|---|---|
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |
Financial Forecast this Year
No analyst forecast available for BridgeBio Oncology Therapeutics Inc..